A common anthelmintic medication used to treat parasites in dogs, fenbendazole (also known as Panacur) exploded in popularity after cancer patient Joe Tippens claimed that it had eradicated his terminal lung cancer. A number of research studies on both animals and humans have revealed that fenbendazole has powerful anticancer effects, especially when combined with specific supplements.

One such supplement is CBD, a natural compound with proven antioxidant properties. When taken together with fenbendazole, it inhibits the proliferation of cancerous cells by blocking their ability to use oxygen. It also reactivates the p53 gene inside the cell, a tumor suppressor. Another effective combination is fenbendazole with vitamin E, curcumin and CBD, which are all natural compounds with multiple health benefits.

These compounds can be encapsulated in micelles and then administered to cancer patients. Micelles have the ability to deliver a drug at a controlled rate, and they can be engineered to prevent the microtubule polymerization needed for cellular growth and division. When fenbendazole and the mTOR inhibitor rapamycin were delivered in micelles, they produced synergistic effects against ovarian cancer cells.

To examine how lung cancer patients perceive fenbendazole for cancer, we conducted four focus groups with 21 participants from a large hospital. We analyzed their responses to questions about how they acquire information, the quality of that information and how they perceive and respond to it. We also compared our findings with previous research on how cancer patients perceive information. fenbendazole for cancer